Understand how pharmaceutical and biotechnology companies use joint ventures to combine capabilities, share investment and pursue strategic opportunities using intelligence from 458 real-world transactions.
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2026 provides comprehensive intelligence on 458 joint venture deals across the global life sciences industry.
Joint ventures provide companies with a distinctive alternative to conventional licensing, collaboration or acquisition. By establishing a jointly owned or controlled business or operating structure, partners can combine technologies, assets, expertise, funding and commercial capabilities while sharing investment, risk and decision-making.
The report brings this activity together in one resource, enabling users to understand who is forming joint ventures, where activity is concentrated, how ownership and governance are structured, what financial terms have been disclosed and how comparable transactions have been established in practice.
Rather than simply identifying transactions, the report combines market-wide analysis with joint venture structure intelligence, leading dealmaker profiles, financial information, detailed transaction records and access to publicly available contract documents where available.
It provides a practical intelligence and benchmarking resource for corporate development, business development, corporate strategy, legal, finance, alliance management and senior management teams evaluating joint venture opportunities.
This provides useful precedent intelligence for internal assessment, transaction planning and negotiation without treating headline values as standalone benchmarks.
Assess joint ventures as a strategic route for combining assets, capabilities, funding or market access.
Business Development teams
Identify relevant precedent transactions, experienced JV counterparties and potential structures.
Companies Considering a Joint Venture
Understand how comparable businesses have approached ownership, contributions, governance and ongoing responsibilities.
Finance and Investment teams
Examine disclosed investment, funding and economic arrangements within real-world joint ventures.
Alliance Management teams
Understand how governance, decision-making and continuing responsibilities have been structured between JV participants.
Competitive and Market Intelligence teams
Track how competitors are using joint ventures to enter markets, access capabilities and pursue strategic opportunities.
Legal and Transaction teams
Review publicly available joint venture agreements to support transaction preparation, structuring and negotiation.
The briefing applies the underlying joint venture intelligence to the customer's own business, assets, technologies or strategic objectives.
Depending on requirements, this can include relevant precedent joint ventures, prospective counterparties, competitor activity, ownership and governance structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2026 provides comprehensive intelligence on 458 joint venture deals across the global life sciences industry.
Joint ventures provide companies with a distinctive alternative to conventional licensing, collaboration or acquisition. By establishing a jointly owned or controlled business or operating structure, partners can combine technologies, assets, expertise, funding and commercial capabilities while sharing investment, risk and decision-making.
The report brings this activity together in one resource, enabling users to understand who is forming joint ventures, where activity is concentrated, how ownership and governance are structured, what financial terms have been disclosed and how comparable transactions have been established in practice.
Rather than simply identifying transactions, the report combines market-wide analysis with joint venture structure intelligence, leading dealmaker profiles, financial information, detailed transaction records and access to publicly available contract documents where available.
It provides a practical intelligence and benchmarking resource for corporate development, business development, corporate strategy, legal, finance, alliance management and senior management teams evaluating joint venture opportunities.
Understand the joint venture landscape
The report analyzes joint venture dealmaking from 2016 to 2026, including:
- Trends in joint venture activity by year
- Phase of development at the time of partnering
- Industry sector
- Therapy area
- Technology type
- Most active joint venture dealmakers
- Leading transactions by disclosed value
- Strategic reasons for establishing joint ventures
- How the use of joint ventures is evolving across life sciences
Understand how joint ventures are structured
Joint ventures require the parties to agree not only what each will contribute, but also how ownership, control, investment and ongoing responsibilities will be shared.Depending on the transaction and available disclosure, users can investigate areas including:
- Ownership and equity participation
- Partner contributions
- Capital and funding commitments
- Governance and decision-making
- Board composition and management
- Intellectual property ownership and licensing
- Research and development responsibilities
- Manufacturing and supply
- Commercialization responsibilities
- Geographic and market rights
- Profit or economic participation
- Additional financing requirements
- Transfer or exit provisions
- Termination and dissolution arrangements
Benchmark leading transactions and disclosed financial terms
The report identifies leading joint venture transactions by disclosed value and provides access to available financial information associated with individual deals.Depending on the transaction, users can investigate:
- Initial partner contributions
- Equity investment
- Funding commitments
- Asset contributions
- Milestone or contingent payments
- Other disclosed financial arrangements
This provides useful precedent intelligence for internal assessment, transaction planning and negotiation without treating headline values as standalone benchmarks.
Identify leading joint venture dealmakers
The report identifies the Top 25 most active joint venture dealmakers and provides transaction histories that enable users to investigate how individual companies have used JV structures.This can help users identify:
- Companies repeatedly establishing joint ventures
- Potential JV counterparties
- Organizations contributing complementary technologies or capabilities
- Companies using JVs to enter new markets or strategic areas
- Competitors pursuing opportunities through jointly controlled structures
- Relevant precedent transactions involving similar objectives
Assess joint ventures alongside alternative transaction structures
A joint venture can offer a different balance of ownership, control, investment and risk from licensing, conventional collaboration or acquisition.The report provides real-world examples that can help users assess when companies have chosen a JV structure and how that choice has supported objectives such as:
- Combining complementary capabilities
- Sharing development or commercial investment
- Entering new markets
- Creating new businesses around technologies or assets
- Maintaining shared strategic control
- Bringing together intellectual property or infrastructure
- Pursuing opportunities that neither party would undertake independently
Learn from real-world joint venture contracts
Where publicly available, the report provides access to underlying joint venture contract documents.These agreements can provide significantly more detail than transaction announcements alone, enabling users to examine how companies have documented matters including:
- Ownership and equity
- Partner contributions
- Governance
- Voting and decision-making
- Intellectual property
- Funding obligations
- Development and commercial responsibilities
- Transfer restrictions
- Exit mechanisms
- Termination and dissolution
Comprehensive joint venture deal directory
The report includes a comprehensive directory of 458 joint venture deals, providing a focused resource for identifying relevant precedent transactions and companies.Deals can be investigated by:
- Company
- Therapy area
- Technology type
- Contract availability
Who should use this report?
Corporate Development and Strategy teamsAssess joint ventures as a strategic route for combining assets, capabilities, funding or market access.
Business Development teams
Identify relevant precedent transactions, experienced JV counterparties and potential structures.
Companies Considering a Joint Venture
Understand how comparable businesses have approached ownership, contributions, governance and ongoing responsibilities.
Finance and Investment teams
Examine disclosed investment, funding and economic arrangements within real-world joint ventures.
Alliance Management teams
Understand how governance, decision-making and continuing responsibilities have been structured between JV participants.
Competitive and Market Intelligence teams
Track how competitors are using joint ventures to enter markets, access capabilities and pursue strategic opportunities.
Legal and Transaction teams
Review publicly available joint venture agreements to support transaction preparation, structuring and negotiation.
Turn market-wide joint venture intelligence into company-specific insight
For qualifying customers, the analyst can also provide a Customized Executive Partnering Briefing alongside the report.The briefing applies the underlying joint venture intelligence to the customer's own business, assets, technologies or strategic objectives.
Depending on requirements, this can include relevant precedent joint ventures, prospective counterparties, competitor activity, ownership and governance structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
Table of Contents
Executive SummaryChapter 1 - Introduction
Chapter 2 - Trends in joint venture dealmaking
Chapter 3 - Overview of joint venture deal structure
Chapter 4 - Leading joint venture deals
Chapter 5 - Top 25 most active joint venture dealmakers
Chapter 6 - Joint venture deals including contracts directory
Deal directory
TABLE OF FIGURES
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3 Rivers Biotech
- 3E Bioventures Capital
- 3SBio
- 1717 Life Science Ventures
- A*STAR Agency for Science
- Technology and Research
- A*STAR Institute of Microelectronics (IME)
- A*STAR’ Institute of Molecular and Cell Biology
- A2A Pharmaceuticals
- AAP Implantate AG
- Abilita Bio
- ABVC BioPharma
- Accellix
- Accumulus Synergy
- Accuray
- Accuredit Therapeutics
- Aceso Life Science
- Acnos Pharma
- ACT Genomics
- Adalvo
- ADC Therapeutics
- Adept Neuro
- Adisseo
- Aditum Bio
- ADM
- Advanced Prenatal Therapeutics
- Advanced Technologies Solutions
- Aequus Pharmaceuticals
- AffaMed Therapeutics
- AffyXell Therapeutics
- Agilis Biotherapeutics
- AgonOx
- Agricultural Research Organization
- AI Longevity
- Aitbiotech
- Aither Ingredient
- Ajlan & Bros
- AJNA BioSciences
- Aker BioMarine
- AKESOgen
- Aleafia Health
- Aleva Neurotherapeutics
- Allied Corp
- Allogene Overland Biopharm
- Allogene Therapeutics
- Alloy Therapeutics
- Ally Bridge Group
- Alpha Tau Medical
- Alpine Hemp Group
- Altus Formulation
- Amarantus BioSciences
- Amedisys
- American Society of Gene and Cell Therapy
- Amgen
- Amyris
- AnchorDx
- Animalcare
- Antoxerene
- Apax Partners
- Aphria
- Apical Biotek
- Apollo Therapeutics
- Arbele
- Arbutus
- ARCH Personalized Medicine Initiative
- Areteia Therapeutics
- Aridis Pharmaceuticals
- Arphio
- Arrowhead Pharmaceuticals
- Arthrosi Therapeutics
- Aruvant Sciences
- Arvinas
- Ascendis Pharma
- Ascendum
- Ascension Saint Thomas
- Asep Medical
- Asklepios Biopharmaceutical
- Aslan Pharma
- Astellas Pharma
- AstraZeneca
- ATAI Life Sciences
- Athenex
- Atlas Healthcare Partners
- ATL Technology
- ATMA Journey Centers
- Atomwise
- ATP
- Atrapos Therapeutics
- Atropos Therapeutics
- Atvio Biotech
- Aulos Bioscience
- Aurum Group
- Autobio Diagnostics
- Auxly Cannabis Group
- Avacta
- Avactis Biosciences
- Avalon GloboCare
- Avalon SteriTech
- Avaria Health & Beauty
- Avivagen
- Avvinity Therapeutics
- Axis Therapeutics
- Bain Capital
- Balboa Nephrology Medical Group
- Bangyi Medical Technology
- Bayer
- BC Neuroimmunology
- Beckley Canopy Therapeutics
- Beckley Foundation
- Becton Dickinson
- BeiGene
- Beijing Genomics Institute (BGI)
- Berry Genomics
- Betaliq
- BevCanna
- BHB Therapeutics
- Bimini Health Tech
- Bio-Based Green Innovation
- Bio-Me
- Bio-Techne
- BioAmber
- BiocurePharm
- Biodist
- Biodyne USA
- BioFields
- Biohealth Innovation
- Biolinear Technologies
- BiolineRX
- BioLite Japan
- Biolojic Design
- Biomedican
- BioMed X Innovation Center
- Biomerics
- bioMerieux
- BioMotiv
- BioNano Genomics
- BioNanoSim
- BioNova Pharmaceuticals
- BioSymetrics
- Blackstone
- Blockshine Technology
- Bloom Fertility
- BLP Management
- Blueberries Medical
- Bluepha
- BNS Ophthalmics
- Boehringer Ingelheim
- BostonGene
- Breakthrough Diagnostics
- BridgeBio Pharma
- Brigham and Women's Hospital
- Bristol-Myers Squibb
- Broad Institute
- Broadwing Bio
- Buck Institute for Age Research
- Bukwang Pharmaceuticals
- Button Capital
- Calysta Energy
- Cancer Research Technology
- Cannabics Pharmaceuticals
- Cannabis Biocare
- Cannabis Therapeutics
- CannAmerica Brands
- CannaRoyalty
- Canopy Health Innovations
- Capna Intellectual
- Capnia
- CardieX
- Casa Schmidt
- Casebia Therapeutics
- CB2 Therapeutics
- CBDerma Technology
- CBDistribution
- CB Therapeutics
- Celexor Bio
- Cellev8 Nutrition
- Celogics
- Cena Life
- Centauri Therapeutics
- Centene
- Centogene
- Centro de Inmunolgía Molecular
- Cerba Research
- Cerevel Therapeutics
- Cerus
- Cesca Therapeutics
- Champions Oncology
- Charles River Laboratories
- Charlotte's Web
- ChemAxon
- Chengdu Gaotong Isotope
- Children's Medical Research Institute
- China-Israel Biological Technology
- China-Singapore Guangzhou Knowledge City
- China Biotech Services
- China Isotope And Radiation
- China National Biotech Group (CNBG)
- Chinese Academy of Sciences
- Chinese Future Industry Investment Fund
- Chinook Therapeutics
- ChromaDex
- Cincinnati Children’s Hospital Medical Center
- Cipla
- CJ CheilJedang
- Clearday
- Cloaked Therapeutics
- Co-Diagnostics
- Cohen Veterans Bioscience
- Colibri Heart Valve
- Collagen Solutions Plc
- Columbus Venture Partners
- Concentrics Research
- Consortium AI
- Contour Therapeutics
- Cooper Companies
- Core One Labs
- Corestone Biosciences
- Corewell Health
- Cornerstone Animal Health
- Corning
- Corona Diagnostics
- CoSara Diagnostics
- Covenant Animal Health Partners
- Cre8ive
- CRISPR Therapeutics
- CROMA Pharma
- Crown Bioscience
- CSPC Pharmaceutical Group
- CureCell
- Cure Therapeutics
- Curi Bio
- Cyclica
- Cyclolab
- CytoBioscience
- Cytotheryx
- Cytovant Sciences
- Daewoong Pharmaceutical
- Dance Biopharm
- DaVita
- dEEGtal Insight
- Deerfield Management
- DemeRx
- Demetra
- Denka
- Denka-KEW Genomics
- Develco Pharma
- DIAN Diagnostics
- Dinova Medtech
- Dixi
- Dizal Pharmaceutical
- DolCas-Tenshi Bioceuticals
- DolCas Biotech
- Dona Blanca
- Dongbao
- Dragonfly Biosciences
- Ductor
- Eastern Capital
- Echo Investment Capital
- Eclipse
- Eden BioCell
- Elanix Biotechnologies
- Elevar Therapeutics
- Eli Lilly
- Embryo Ventures
- Emerald Organic Growth
- Emergence Therapeutics
- EmoCellix
- Emory University
- Emosis
- Entheogenix Biosciences
- EpiPharma
- ERS Genomics
- EssilorLuxottica
- Eurofarma
- Everads Therapy
- Evergreen Nephrology
- Evero Health
- Evotec
- Excellmab
- Exemplar Genetics
- Exscientia
- FairJourney Biologics
- Fannin
- Faxian Therapeutics
- FCM Global
- Fedecore
- Fedora Pharmaceuticals
- FerGene
- Fermbox Bio
- Ferring Pharmaceuticals
- Filament Health
- Fio
- FJ Pharma
- Flora Growth
- FloVaria
- Flow Pharma
- Foresite Capital
- FORMA Therapeutics
- Fosun Pharmaceutical
- FoxBio
- Fox Chase Cancer Center
- Frazier Healthcare Ventures
- Fresenius Kabi Pharmaceuticals
- Frontage Laboratories
- FSD Pharma
- Fujitsu Laboratories
- Full Spectrum Biosciences
- Futura Medical
- Fuzionaire Diagnostics
- Fuzionaire Radioisotope Technologies
- G3 Therapeutics
- Galvani Bioelectronics
- Gauss Surgical
- GC Aesthetics
- GEDiCube
- Geisinger Health System
- Genesis MedTech
- Gene Therapy Research Institution
- Genetic Technologies
- Genevant Sciences
- Geninus
- Genome Institute of Singapore
- Genomix Scientific
- Genomma Lab Internacional
- GeoVax
- German Research Center for Artificial Intelligence
- Gerresheimer
- GHO Capital
- Ginkgo BioWorks
- Glaxo Group
- GL Brands
- GLG Pharma
- Global Canna Labs
- Global Drug Development Centre (GDCC) China
- GNC
- Golden Mountain Partners
- Gore Range Capital
- Great Bay Bio
- Grenco Science
- Grow Biotech
- Grunenthal
- Grupo Curativa
- Grupo Natac
- GSK
- GtreeBNT
- Guangzhou Boji Medical Biotechnological
- Guangzhou Ruianbo Pharmaceutical Technology
- Guangzhou Ruiao Biopharmaceutical Technology
- Guangzhou Xiangxue Pharmaceutical
- Hainan Sihuan Pharmaceutical
- Halberd
- HaloVax
- Hancom Group
- Hangzhou Diagens Biotechnology
- Haoyue Group
- Harvard University
- HCA Healthcare
- Healium Medical
- HealthBanks Biotech
- HealthMed Services
- Hefei Meifu Biotech
- Hefei Sageland Biotechnology
- Heidelberg Engineering
- Heidelberg Pharma
- HekaBio
- Helomics
- Hemispherian
- Henry Schein
- Heritage Cannabis
- Herman Holdings
- Hi-Tech Pharmaceuticals
- HiFiBio
- HighRes Bio
- HMNC Brain Health
- Hollister Biosciences
- Hologen AI
- Homology Medicines
- Honor Epic Enterprises
- Horizon Discovery
- Horizon Pharma plc
- Hoth Therapeutics
- Hovione
- Huakang Biomedical
- hVIVO
- Hybrid Pharm
- I-Bridge Capital
- IBA
- iBio
- Icahn School of Medicine at Mount Sinai
- ICAN
- Icon
- ICU Medical
- iFLYTEK
- Immorna
- ImmuneCyte Life Sciences
- ImmuneOncia Therapeutics
- ImmunityBio
- Impact NRS
- IMPACT Therapeutics
- Imperial College London
- Imutex
- Indegene Lifesystems
- India Colorada
- Indivumed
- Infomed
- InfuSystem Holdings
- Inmagene Biopharmaceuticals
- Innoplexus
- Innovation Network Corporation
- Innovative Immunotherapy Alliance
- Insilico Biotechnology
- Institut Gustave Roussy
- Institut Pasteur of Shanghai at the Chinese Academy of Sciences
- Intercontinental Marketing
- International Research Center on Cannabis and Mental Health
- International SOS
- International Vitamin
- Intuitive Surgical
- Invento Research
- Invictus MD Stategies
- Invitrocue
- InvivoCue
- INVO Bioscience
- IONTAS
- IPMC
- IPS Specials
- ITM Isotopen Technologien
- Ix Therapeutics
- JAGUAHR Therapeutics
- Jaguar Health
- Janssen Pharmaceuticals
- Japan Industrial Partners
- Japan Medical Isotope Technology Development
- JAYEX Technology
- JCR Pharmaceuticals
- Jeffs' Brands
- Jeune
- Jiangsu Recbio Technology
- Jiangsu Vedkang Medical Science and Technology
- Johnson & Johnson
- Johnson & Johnson Innovation
- Jointechlabs
- Joint Venture Partner Group
- JRT Nurseries
- Junshi Biosciences
- Juvenescence
- Juvenomics
- Jvion
- Kadmon Pharmaceuticals
- Kaiima Bio-Agritech
- Kaiser Foundation Research Institute
- Kane Biotech
- Kangmei Pharma
- Kantaro Biosciences
- Keensight Capital
- Kemwell BioPharma
- Ketabon
- KEW
- Kindred Healthcare
- Kings Group
- Kinnate Biopharma
- Kiromic Biopharma
- Kishida Chemical
- Kite Pharma
- Knopp Biosciences
- Kraig Biocraft Laboratories
- Krystal Biotech
- Kubota Pharmaceutical
- Kurma Life Sciences Partners
- Kyma Therapeutics
- Kyowa Hakko Kirin
- Lab1636
- LabCentral
- LeaderMed Health Group
- Lenus Therapeutics
- LG Chem
- LifeArc
- LifeCell
- Lifera
- Lifestyle Delivery Systems
- LifeTech Scientific
- Liht Cannabis
- Lobe Sciences
- Lonza
- Lucidam
- Lyndra Therapeutics
- Lyphe Group
- Maccura Biotechnology
- Magdalena Biosciences
- MAGiQ Therapeutics
- Magnolia Extracts
- Malaghan Institute
- Mannin Research
- MapKure
- Maple Leaf Green World
- Massachusetts General Hospital
- MaSTherCell
- Mawson Infrastructure
- Mayo Clinic
- Maze Therapeutics
- McKesson
- McLean Hospital
- MD Anderson Cancer Center
- MedAxiom
- Medcolcanna Organics
- Medesole Healthcare and Trading
- Medesole INVO Bioscience
- Medical & Biological Laboratories (MBL)
- Medical Food Solutions Research
- Medicrea
- MedinCell
- Medipal Holdings
- Medpace
- MedQuest
- Medspray
- Medtronic
- Meiji Seika
- MeiraGTx
- MemorialCare Health System
- Memorial Sloan Kettering Cancer Center
- Merck KGaA
- Metronom Health
- Mimi’s Rock
- Minerva Foods
- MiNiSV
- Mino Labs
- MitoCareX Bio
- Mitsubishi Pharma
- Mitsui
- Mizuho Capital
- Mobidiag
- Mobvoi
- Molipharma
- Molnlycke Health Care
- Mota Ventures
- Motion Medical
- MTP Material
- Mundimed
- MVI Health
- Mycotopia Therapies
- Mycrodose Therapeutics
- Myomo
- Myovant Sciences
- N1 Life
- NacuGen Therapeutics
- Nankai Hospital
- Napa Therapeutics
- Napoltec Life Sciences
- Natac Solutions
- National Cerebral and Cardiovascular Disease Research Center
- National Green Biomed
- National Institute for Biotechnology in the Negev
- National Resilience
- National Surgical Care
- NEC
- Nemaura Medical
- Neopharma
- Neostell
- Neovacs
- NephCure Kidney International
- Neptune Technologies & Bioressources
- NetraMark
- NetraPharma
- Neuboron Medtech
- Neuboron Therapy System
- NeuroTheryX
- NewCanna Hub
- New Wave Ventures
- New York Genome Center (NYGC)
- Nexel
- Nicox
- Nikkol
- NineteenGale Therapeutics
- Nisarga Biotech
- NLC Pharma
- Noble Growth
- North Mississippi Health Services
- Northwell Health
- Not-So-Gentle Tea Company
- Novaliq
- Nova Mentis Life Science
- Novant Health
- Novara Therapeutics
- Novogene
- Novo Nordisk
- NTT Medical Center Tokyo
- NuAxon BioScience
- Nucleus RadioPharma
- Nuritas
- Nutra Manufacturing
- Nvidia
- Ocean Biomedical
- OG Laboratories
- OncoQuest
- OncoStatyx
- Oncotelic
- OncoVent
- One BioMed
- Onegevity
- One Small Planet
- One World Pharma
- Opiostop
- OPKO Health
- Optasia Medical
- OptiBiotix
- Oramed Pharmaceuticals
- Oravax Medical
- OrbiMed Asia Partners
- Orgenesis
- Orphan Therapeutics Accelerator
- Orthopaedic Research UK
- Otsuka
- Overland ADCT BioPharma
- Overland Pharmaceuticals
- Oxford BioMedica
- Oxford Biomedica Solutions
- Oxford MEstar
- Oxford Sciences Innovation
- Palantir
- Panacea Biotech
- PanTera
- Paragon Therapeutics
- PathoQuest
- Peak Pharm Labs
- PENTAX Medical
- PentixaPharm
- Penumbra
- PeptiAID
- PeptiDream
- PeptiGrowth
- Perennial
- PerkinElmer
- Pfizer
- PharmaCielo
- Phathom Pharmaceuticals
- Phinest Cannabis
- PhytoChem Technologies
- Pillar Biosciences
- Pinnacle Hill
- Pittsburgh Life Sciences Greenhouse
- Pivotal bioVenture Partners
- Pivot Pharmaceuticals
- Pleasure Peaks
- Pluristem Therapeutics
- Population Health Partners
- Portage Glasgow
- Portage Pharmaceuticals
- Poseidon Innovation
- PPD
- PRA Health Sciences
- Premas Biotech
- Premier Biomedical
- Prenetics
- Prime Healthcare Services
- Priovant Therapeutics
- ProMedica Health System
- Promethera Biosciences
- Prometic Life Sciences
- ProMIS Neurosciences
- Prospekt Medical Caspian
- Provision Asia
- PsyBioMed - Australia
- Psyence Therapeutics
- Pure Extracts Technologies
- Pyxis Oncology
- QIAGEN
- Q Therapeutics
- Quanterix
- Quantum Surgical
- Quest Diagnostics
- Radient Technologies
- Radiopharm Theranostics
- Radiopharm Ventures
- RadNet
- Rafarm
- Rafarma Pharmaceuticals
- Raizen Energia
- Rare Expertise
- RavenQuest BioMed
- Recipharm
- Refana
- Regenacy Pharmaceuticals
- Regencell Bioscience
- Relation Therapeutics
- Relay Medical
- Reliance Animal Health Partners
- RenalytixAI
- Rensselaer Polytechnic Institute
- RENX AI Labs
- Replay
- ReproCell
- Resilience
- Resmed
- Respiratory Motion
- Resyca
- Revive Therapeutics
- Rochal Industries
- Roche
- Rocket Science Health
- Rodo Medical
- Roivant Sciences
- Romulus Titan
- Roswell Park Cancer Institute
- Rxilient Biotech
- Ryzur Medical Investment
- Samsung Bioepis
- Sanara MedTech
- Sanofi
- SanReno Therapeutics
- Sansure Biotech
- Sanuwave Health
- Sartorius
- SBI Capital Markets
- Scailyte
- ScaleReady
- Schrodinger
- Sciex
- Scilex Holding
- Scintomics
- SciSparc
- SCK CEN
- Scohia Pharma
- SCOUT
- Scripps Health
- Seaspring
- Seegene
- SEEK
- Select Medical
- SELVAS Healthcare
- SEngine Precision Medicine
- Sensyne Health
- Sepset Biosciences
- Shandong Zhongbaokang Medical Implements
- Shanghai Chonghe Marine Industry
- Shanghai Hi-Tech Nutraceuticals
- Shenzhen Arimab Biopharmaceuticals
- Shenzhen Hepalink Pharmaceutical
- Shenzhen Neptunus Interlong Bio-Technique
- Shenzhen Rhegen Biotechnology
- Shenzhen Yunma Biotechnology
- Shin Nippon Biomedical Laboratories
- Shockwave Medical
- SIFI (Societa Industria Farmaceutica Italiana)
- Silo Pharma
- Singlera Genomics
- Sinovant Sciences
- Sirnaomics
- Sixense Enterprises
- SK Biopharmaceuticals
- SkinBiotix
- Skyline Medical
- Smart Medicines GMP
- SoftBank Robotics Group
- Solaris
- Soleno Therapeutics
- Sonic Healthcare
- SOPHiA Genetics
- Sorrento Therapeutics
- Sorse Technology
- Sosei
- Southern Cross University
- Spectral Medical
- SpringWorks Therapeutics
- Sproutly
- Spydasilk Enterprises
- Starbuds
- State of Victoria
- STATKING Clinical Services
- Steep Hills Labs
- Stellar Biotechnologies
- STEM Animal Health
- Stem of Hope
- StemoniX
- StillCanna
- Stonehaven Incubate
- Strategic Vaccines
- Sumitomo Mitsui Banking Corporation
- SunGen
- Syena
- Symbasis
- Synbiotics
- Syneos Health
- Synlogic
- Sysmex
- Tactical Relief
- TAE Life Sciences
- Tahoe Therapeutics
- TaiRx
- TaiRx US
- Taiwan Bio-Manufacturing
- Takeda Pharmaceutical
- Takenaka
- Talem Therapeutics
- Targetrin Therapeutics
- Tasso
- Tauriga Sciences
- TechCare
- Technology Acceleration Partners
- Technopath Clinical Diagnostics
- Tecres
- Tenshi Kaizen
- Tessa Therapeutics
- Tetra Bio-Pharma
- Thar Process
- The Alchemists Kitchen
- Theracell
- Therapix Bio
- Thermo Fisher Scientific
- ThermoGenesis
- Thorne HealthTech
- Thorne Research
- Thousand Oaks Biopharmaceutical
- Tikun Olam
- Titian Software
- TNK Therapeutics
- Tnuva Group
- Todos Medical
- Tonghua Dongbao Pharma
- TotalEnergies
- Touchlight
- TranScrip
- Translational Medicine Accelerator
- Trellis Growing Solutions
- Trellis Growing Systems
- TriArm Therapeutics
- TryptageniX
- UltraSight
- United BioSource
- University College London
- University of Arkansas
- University of California
- San Diego
- University of Cambridge
- University of Glasgow
- University of Hong Kong
- University of Manchester
- University of Maryland
- University of Michigan
- University of Northern Colorado
- University of Oxford
- University of Pittsburgh
- University of West Indies
- Vaccines Lab SDN BHD
- Vapium
- Veeva Systems
- Venus Medtech
- Verde Leaf
- Verily
- Vertical Companies
- ViaMune
- Victa Biotherapeutics
- Vifor Pharma
- Viralgen
- Virion Therapeutics
- Virtual Psychedelics
- VISEN Pharmaceuticals
- Visirna Therapeutics
- VivaVision Biotech
- Vivo Capital
- Vivos Therapeutics
- Voltron Therapeutics
- Vyaire Medical
- Vyripharm
- Walgreens
- WardMM
- Washington University in St Louis
- Wheeler Bio
- Wilson Wolf
- World Class Extractions
- WSG Group
- Wuhan Rhecogen Biotechnology
- Wuxi Apptec Laboratory Services
- WuXi Biologics
- Wuxi STA
- WuXi XDC
- Wyss Center
- X-chem
- Xcellomics
- Xerox
- Xlife Sciences
- YASKAWA Electric
- Yissum Research Development
- Yongyi Biotechnology
- Yongyi Hi-Tech Nutraceuticals
- Yuhan Corporation
- YuYang DNU
- Zann Medical Technology
- Zerion Pharma
- Zhaotai Group
- Zhejiang Jiuzhou Pharmaceutical
- Ziopharm Oncology
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
